Skip to content

Evaluation of the effectiveness of interalipid infusion for patients with a history of 2 unsuccessful embryo transfers

Evaluation of the effectiveness of interalipid infusion for patients with a history of 2 unsuccessful embryo transfers

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140305016858N5
Enrollment
80
Registered
2021-06-19
Start date
2021-05-22
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failler. Complication associated with artificial fertilization, unspecified

Interventions

Intervention 1: Control group:Intervention group (Intralipid receptor): Intralipid receptor 20% solution in 250 cc of sterile saline, which is administered within two hours. Once between days 4 to 9 o

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients who have a history of 2 embryo transfers are sampled. Patients who are over 18 to 40 years old and have the necessary criteria for the IVF process All mothers with a history of infertility

Exclusion criteria

Exclusion criteria: Mothers with dangerous chromosomal abnormalities Mothers with dangerous abnormalities of antiphospholipid syndrome or positive thrombophilia test Mothers with endocrine disorders Mothers with hyperlipidemia disorders Mothers who were allergic to eggs and their products Mothers over 40 years old

Design outcomes

Primary

MeasureTime frame
Positive pregnancy test. Timepoint: Two weeks after transfer. Method of measurement: In Imam Khomeini Infertility Center, pregnancy test is performed by ELISA method.

Secondary

MeasureTime frame
Record fetal heart rate at 6 weeks of gestation. Timepoint: Six weeks of pregnancy. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sepideh Peyvandi

Mazandaran University of Medical Sciences

drspeyvandi@mazums.ac.ir+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026